hero section gradient
15 handpicked stocks

Apocalypse Portfolio

This carefully selected collection of stocks represents companies that could thrive during major societal disruptions. Our team of analysts has identified businesses providing essential survival goods and services, from power generation to food security, that become invaluable when conventional systems falter.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and concise investor takeaways based on the provided market capitalisation breakdown for the Apocalypse Portfolio.

Key Takeaways for Investors:
  • Large-cap dominance generally implies more stability and lower volatility, often tracking broad-market movements rather than idiosyncratic swings.
  • Suitable as a core holding for diversified portfolios, not primarily a speculative allocation for rapid gains.
  • Expect steady, long-term value accumulation rather than aggressive short-term upside; returns may be moderate.
Total Market Cap
  • GNRC: $11.30B

  • POWW: $175.67M

  • BYRN: $471.33M

  • Other

About This Group of Stocks

1

Our Expert Thinking

This portfolio is built around companies providing critical products for surviving systemic breakdowns. The investment thesis assumes these businesses will see surging demand during crises when traditional infrastructure fails, as their products support self-sufficiency and security in unstable times.

2

What You Need to Know

These companies focus on tangible, durable products that enable independence—from off-grid power generation to food storage, water filtration, and personal security. This collection acts as a defensive hedge against systemic global risks and high-impact, low-probability events.

3

Why These Stocks

We've selected companies whose products become indispensable in emergency scenarios. Each business provides tools for self-sufficiency that would be crucial during widespread disruptions. Growing awareness of supply chain fragility and climate instability increases the relevance of these preparedness-focused businesses.

Why You'll Want to Watch These Stocks

🌪️

Crisis-Proof Businesses

These companies provide essentials that become invaluable during emergencies. As global instability increases, their products shift from optional to necessity.

🔋

Skyrocketing Demand Potential

During major disruptions, demand for self-sufficiency tools can explode overnight. These companies are positioned to meet the surge when conventional systems fail.

🛡️

Hidden Portfolio Protection

Adding survival-focused stocks provides a unique hedge against systemic risks that traditional safe havens might not cover, potentially balancing your overall investment strategy.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions